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Abstract 
 
Green tea consumption has been associated with a reduction in cardiovascular disease risk factors. 
However, there is little evidence examining its potential differing effect between younger and older 
populations, while little is known on its effect on the circulatory system when oxygen demand is 
higher.  
Therefore the aim of this study was to evaluate the short-term effects of green tea consumption on 
microvascular functioning in both an older and younger population.  
Fifteen young [24 (4.0)] and fifteen older [61 (4.0)] participants, consumed two cups of green tea 
daily for 14 days. We used Laser Doppler Flowmetry to assess cutaneous microvascular function 
and Transcutaneous Oxygen Pressure to assess skin oxygen tension. Systolic and diastolic blood 
pressure were also assessed on both visits.  
We observed significant improvements in axon-mediated microvascular vasodilation for the 
younger group [1.6 (0.59) vs 2.05 (0.72), p<0.05] and the older group [1.25 (0.58) vs 1.65 (0.5) 
p<0.05]. Improvements in skin oxygen tension were also noted for both groups in both noted 
TcPO2 measures (i.e. 1.25 (0.58) vs 1.65 (0.5) (p<0.05), for ΔTcPO2max for the older group, 
between visits) respectively. Improvements were also observed for systolic blood pressure in both 
the younger [120 (10) vs 112 (10), p<0.05] and older group [129 (12) v 124 (11), p<0.001].  
In conclusion, we observed statistically-significant improvements in microvascular function and 
skin oxygen tension. Our results suggest that green tea may prove beneficial as a dietary element in 
lifestyle interventions aiming to lower cardiovascular disease risk, in both older and younger 
populations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
 
Cardiovascular disease (CVD) is the leading cause of death worldwide (Nichols et al. 2014), and 
responsible for 1 in 4 deaths in the United Kingdom (Townsend et al. 2015). There are a number of 
factors which contribute to its development with The British Heart Foundation categorising high 
saturated fat and high sodium intake as known risk factors (Townsend et al. 2015).  
 
Green tea (GT) and particularly its high quantities of catechins have been the subject of extensive 
research and have subsequently been associated with a reduction in CVD risk makers by improving 
endothelial functioning (Alexopoulos et al. 2008). The endothelium is the inner lining of all blood 
vessels and serves as a selectively permeable barrier between blood and tissue. It plays an essential 
role in the homeostasis of vascular tone and it requires an intricate balance of endothelium 
dependant relaxing and contracting factors (Félétou 2011). 
 
Nitric oxide (NO) is a particularly important factor and is an endothelium dependant relaxer, 
generated during the conversion of L-arginine to L-citrulline by endothelial NO-synthase (Vasan et 
al. 2002).  It works through counteracting the actions of contracting factors, including angiotensin-
11 and endothelin-1. Various studies have isolated specific components of GT and observed an 
augmentation of NO status (Loke et al. 2008).  Similarly, oral administration of catechins increased 
NO levels and also decreased enodthelin-1 concentrations (a vasoconstrictor) (Persson et al. 2006). 
However, the precise constituents within GT, responsible for health benefits and indeed their exact 
mechanisms of action, are not clear. In vivo, mice studies have revealed that consumption of GT 
catechins may decrease the risk of atherosclerosis by improving the bioavailability of NO and by 
causing vasorelaxation, however, data appeasing this in humans is presently insufficient 
(Velayutham et al. 2008). One study postulated that catechins could be the constituent responsible 
for their observed improvements in cell viability by reducing the intracellular Reactive Oxygen 
Species accumulation (Horáková 2011).  
Endothelial dysfunction is a term used to describe diminished production of the supply of NO and a 
subsequent lack of vasodilation in the artery and is considered to be an indicator of future 
cardiovascular events (Deanfield et al. 2007).  Short-term GT consumption induced a rapid 
improvement in endothelial dysfunction in ‘healthy’ smokers in a study by Kim and colleagues 
(2006). The study found that after 2 weeks of GT consumption, there was a significant positive 
amelioration in endothelial function. 
 
All major CVD risk factors, including high blood cholesterol, hypertension, diabetes and smoking 
have been shown to be accompanied by endothelial dysfunction (Hadi et al. 2005). The assessment 
of endothelial function and dysfunction is therefore of great interest. 
 
There is mounting epidemiological evidence to suggest GT may lower the risk of CVD (Kuriyama 
et al. 2008), however epidemiological studies may prove difficult in isolating cause and effect. 
Further, whilst positive results have been observed when participants were given GT extracts 
(Nagao et al., 2007) the particularly high catechin content contained within these may not 
accurately represent those ingested through GT beverages. A standard cup of beverage GT can 
contain 100mg of catechins (dependent on origin and preparation) in comparison to extract 
formulas which can contain almost four times this amount (Astil et al.2001; Dullo et al. 1999).  
 
We therefore conducted a study aiming to observe the short-term effects of beverage GT on the 
micro-circulation at rest and during sub-maximal exercise testing, making a comparison between 
two healthy, sedentary populations (e.g. “younger” vs an ‘older”). We sought to examine whether 
GT exerts a physiological effect when oxygen demand is higher as well, as the circulatory system is 
known to react differently during rest and provocation (Abraham et al. 2003). 
We hypothesized that GT consumption would have an overall positive effect on the endothelial 
function in both the older and younger healthy, sedentary groups, with the effects being greater in 
the older population.  
  
For the purposes of this study, we used Laser Doppler Flowmetry (LDF) and Transcutaneous 
Oxygen Pressure (TcPO2). LDF combined with local heating of the skin (usually at the forearm) 
provides a simple method for examining microvascular and endothelial function (Tew et al. 2011). 
TcPO2 is a non-invasive monitoring of the oxygen tension in the skin, providing us with a direct 
indication of the microvascular function. 
 
Methods 
Ethical Approval 
The study was approved by Sheffield Hallam University Health and Wellbeing Ethics Committee 
(Institutional Review Board; HWB-S&E-24) and conformed to the standards set by The Declaration 
of Helsinki.   
 
Participants 
Fifteen healthy young participants aged 18-35 and fifteen older participants aged 55-75 participated 
in the study. Recruitment took place through The University of Sheffield Volunteers email, local 
community groups (University of the Third Age Group) and through word of mouth. Posters were 
also placed around the University campus. 
All participants were medically screened beforehand and for each of them, height and weight were 
recorded and a body mass index was subsequently calculated. Body mass index was calculated 
using the following standard equation BMI (kgm2) = (weight kg / (height m) 2).   The participants 
resting systolic and diastolic blood pressure were also taken. Exclusion criteria included any overt 
chronic disease that would affect micro- or macro- vascular functioning (e.g. diabetes, systemic 
sclerosis, hypertension and cardiovascular disease), pregnancy, smoking as well as regular tea-
drinking (e.g. more than 4 cups per week). 
 Each participant provided written informed consent prior to participating in the study. 
 
Protocol 
Eligible participants were required to visit the Centre of Health and Wellbeing at Sheffield Hallam 
University on two occasions. On each visit, participants were required to undergo a microvascular 
assessment using LDF and a sub-maximal exercise test in which skin oxygen tension was assessed. 
Participants were given 100% green tea, of Indian origin in the form of 2.5g tea-bags (Tesco, 
Welwyn Garden City, UK). Participants were instructed to consume two standard cup sizes (250ml) 
a day for 14 days. We stipulated two cups a day as this can be considered achievable to implement 
for the majority of the population, with findings suggesting the average British individual already 
consumes 17 cups throughout the week (Contact the Elderly 2015).  
 In addition, all participants were instructed to avoid adding milk to the beverage and to steep the 
teabag for 3-4 minutes (Ryan & Petite, 2010).  Participants were instructed to consume the first cup 
upon waking and the final cup in the afternoon, independent of food consumption. Participants were 
instructed to abstain from caffeine 2-3 hours prior to the assessments, so as to eliminate the 
confounding effect caffeine may have produced on vasorelaxation (Echerverri et al. 2010). 
Finally, participants were asked not to change their usual activities and dietary habits (aside from 
consuming the GT) over the next 14 days so as to best decrease the susceptibility of confounding 
factors. Participants were also given a 14-day log and were asked to note the times of GT 
consumption. 
 
Laser Doppler Flowmetry (LDF) Measurements 
 A site on the upper right forearm was selected (care was taken to avoid visible veins, body hair and 
damaged or irritated skin). The site location was marked and measured from the wrist so as to 
improve reproducibility of the location for the follow up visit. The site was first cleaned using an 
alcohol sterilization wipe to remove the superficial dead layer of skin, as this has been proposed to 
improve the reproducibility of the technique (Puissant et al. 2013).   
Regions of the response were then recorded (Table 1).  Cutaneous vascular conductance (CVC) 
calculations were made by dividing LDF values by the participants mean arterial pressure. These 
values are expressed as percentages of the peak response to heating: %CVC MAX = 
(CVC/maximum CVC) x 100. 
Response  Time  
Baseline The arithmetic mean of the last 2 minutes of the initial 5 
minute period. 
Initial peak  The arithmetic mean of the highest consecutive 30 
second period within the distinct initial hyperaemic 
response. 
Plateau  The arithmetic mean of the last 2 minutes of heating at 
42°C. 
Maximum  The arithmetic mean of the last 2 minutes of heating at 
44°C. 
 
Table 1: Laser Doppler Flowmetry regions of recorded responses  
 
All tests were conducted in a temperature controlled room with a constant ambient temperature of 
24°C. Throughout LDF assessments heart rate and diastolic and systolic blood pressure were 
recorded from the left arm at 5 minute intervals throughout the protocol (Dinamap Dash 2500, GE 
Healthcare, USA). Baseline skin blood flow data was recorded for 5 minutes with the local heating 
disc temperature set at 30 degrees. Following this, rapid local heating was initiated to obtain 
maximal vasodilation and the temperature was increased by 1 degree every 10 seconds until 42°C 
were reached. This was then maintained for 30 minutes. After this, the temperature of the probe was 
quickly increased to 44°C for a final 10 min to obtain maximal vasodilatation (Tew et al. 2011).   
 
Transcutaneous Oxygen Pressure (TcPO2) Measurements and Sub-Maximal Exercise Tests 
At the end of each visit, a sub-maximal test was also undertaken using a standard ergometer cycle 
while measuring the oxygen tension of participants, which consisted of four rounds. (Table 2).  
Each participant was allowed to stop the sub-maximal test when they felt that they had reached their 
exertion limit.  
 
Minute Rounds 
 
Resistance  Speed RPM 
(Rotations per minute) 
Round 1: 5 mins 0.5kg 80RPM 
2 minute rest -Rest- -Rest- 
Round 2: 5 mins 0.75kg 80 RPM 
2 minute rest -Rest -Rest- 
Round 3: 5 mins 1kg 80 RPM 
2 minute rest -Rest- -Rest- 
Round 4: 5 mins  1.25kg 80 RPM  
2 minute rest -Rest- -Rest- 
 Power (watt) = weight of 
load (Kg) * revolutions per 
minute (rpm). 
 
 
Table 2: Sub-maximal testing protocol  
 
During the sub-maximal test, oxygen tension was measured using TcPO2 in which sensors were 
non-invasively attached onto the skin and allowed to heat. The heat produced by the sensor causes a 
dilatation of the skin blood capillaries, which increases blood flow and causes a subsequent 
diffusion of oxygen through the skin to the sensor. The sensor is able to measure TcPO2 value(s) 
inwardly through an electrochemical process. 
 Measurements were performed using the TINA TCM400 TcPO2 device (Radiometer, Copenhagen, 
Denmark). The temperature of the probe was set to 44.5°C to allow maximal skin vasodilatation, 
thereby decreasing the arterial to skin surface oxygen pressure gradient. Afterwards, the TcPO2 
measurements were automatically temperature-corrected to 37°C by the TINA device. The electrode 
was placed slightly below the right scapula on the back away from any bone. 
 Fixation rings were used to hold the probe in-place and this was filled with two small drops of 
contact fluid before attachment to the sensor. The fluid is then heated causing the skin to 
subsequently dilate. Heart rate was also recorded throughout the duration of the sub-maximal test. 
For the purposes of this study we defined TcPO2 as raw values of the participant’s oxygen 
perfusion, obtained directly from Transcutaneous Oxygen Pressure machine recordings (Table 3).  
 
TcPO2 Quantity Definition 
Baseline The arithmetic mean of maximum TcPO2 at rest. 
TcPO2max The highest TcPO2 value recorded every minute of 
exercise or at rest. 
Maximum change from 
Baseline (ΔTcPO2max) 
The outcome of the subtraction of Baseline from 
TcPO2max: e.g. TcPO2max – Baseline 
Change in Transcutaneous 
Oxygen Pressure (ΔTcPO2) 
The average sum of the change from Baseline 
at rest and exercise period: e.g. (Σ (ΔY1…n)/n) = ΔTcPO2 
 
Table 3: TCpO2 quantities used in our study and their definitions 
 
Self-perceived exertion and pain 
 During sub-maximal exercise testing, we also recorded the participants’ perceived pain and 
exertion was measured every minute, using the CR10 (rate of perceived pain) and the rate of 
perceived exertion (RPE) (Borg, 1970). The CR10 scale contains 20 different perceived pain 
intensity levels, with 0 corresponding to no perceived pain through to 20 corresponding to 
maximum pain. The RPE scale contains 14 numerical values beginning at the number 6 which 
corresponds with no exertion and 20 corresponding to maximum exertion. 
 
TcPO2 profiles  
As suggested by Ouedraogo and colleagues (2011) we categorised study participants as “healthy” 
and “diseased”, according to their TcPO2 profiles. Type 1 corresponding to healthy; characterised 
by an initial increase during exercise. Type 2 corresponding to unhealthy; characterised by initial 
decline during exercise. 
 
 
Statistical analysis 
 An Analysis of variance (ANOVA) was carried out to compare the effectiveness of supplements of 
GT for two weeks period on BMI, Blood Pressure, perceived pain and exertion and TCPO2 and 
microvascular LDF values (version 18.0 for windows, SPSS Inc., Chicago Illinois). The dependent 
variables consisted of the variables measurements before and after intervention period. Participants’ 
measurement before the intervention period was used as base line values for analysis.  Preliminary 
checks were conducted using the Kolmogorov-Smirnov goodness of fit test to ensure that there 
were no violations of assumptions of normality, linearity, homogeneity of variances, homogeneity 
of regression slopes, and are reliable measurements of covariates. Significant level for all tests was 
set at p=0.05. The number of days between sessions and number of doses missed were used to 
calculate the participants’ overall compliance. Differences for compliance between groups were 
calculated using independent t-tests. Data was stored and transformed within Microsoft Excel 
(Microsoft Office 2013) and statistical analysis was performed using Predictive Analytics SoftWare 
Statistics v18.0 (SPSS: An IBM Company, New York, USA). 
 
Results 
Participant characteristics 
 
Fifteen younger participants were deemed eligible to participate and completed all measures of the 
study. The fifteen younger participants had a mean age of 24 (4.0), with a mean BMI of 24.5 (4.2). 
Mean systolic blood pressure was 120 (10) and there was a diastolic mean of 67 (7.0). 
Similarly, fifteen older participants aged 55-75 were recruited and completed all assessments. Seven 
participants in the older group were female, eight were male. The fifteen older participants had a 
mean age of 61 (4.0) with a mean BMI of 23.8 (4.6). The mean systolic blood pressure was 129 
(12) and the mean diastolic blood pressure was 73 (5.0). 
 
  
 
 
 
 
 
 
 
 
*p<0.05 between visits (within groups) ** p<0.001 between visits (within groups) 
† p<0.05 between groups (at the same time-point) 
 
Table 4:  Characteristics of the experimental groups 
Participant characteristics are presented in Table 4. There were no statistically significant 
differences between groups at baseline for body mass index (BMI), stature, resting heart rate, or 
systolic blood pressure. There was however a significant difference between groups for resting 
diastolic blood pressure with a lower value noted in the younger groups. 
 
Side effects 
No participants withdrew from the study because of adverse events associated with the treatment. 
One participant noted mild gastrointestinal discomfort upon commencing the GT however this 
resolved naturally after the first day. There were no major adverse events reported during the study. 
 
Compliance 
GT consumption compliance was 26 (2) units for the younger group and 27 (1) units in the older 
group. No significant difference was found when comparing groups.  
Blood Pressure, BMI and Weight 
 Group A (younger group) Group B 
(older group) 
 Visit 1   Visit 2 Visit 1   Visit 2 
Gender 7 male, 8 female 8 male, 7 male 
Age (years) 24 (4)† 61 (4) 
Resting BP (systolic) 120 (10)       112 (10)** 129 (12)      124 (11)* 
Resting BP (diastolic) 67 (7)†      65 (6) 73 (5)       72 (8) 
Height (cm) 170 (8)      169 (7) 
Weight (kg)  71.4     
(15.5) 
      71.2 (15.7)     66.7(11.1)       66(11.2) 
BMI (kg/m2) 24.6 (4.2)      24.6 (4.2)      23.8 (4.6)       23.5(4.4) 
GT Consumption 
Compliance (units) 
26 (2)        27 (1) 
There were no statistically-significant differences between groups for BMI or diastolic blood 
pressure at baseline or at the end of the intervention. However, there was a significant difference for 
systolic blood pressure measurements, at the end of the intervention for both younger (P < 0.05) and 
older participants (p<0.001).  Whilst both groups also demonstrated a pre- to post- GT consumption 
decrease in diastolic blood pressure, this was not statistically-significant in any of the groups. No 
significant changes were noted in either BMI or weight. 
 
Raw Cutaneous Vascular Conductance (CVC)  
Baseline 
Raw CVC 
There were no statistically significant differences between groups for Raw CVC baseline readings 
at any visit. Raw CVC baseline recordings within groups improved however this too was not 
significant in either of the two groups (Table 5). 
 
% CVC MAX 
There were no statistical differences between groups for % CVC MAX baseline readings at either 
the beginning or at the end of the intervention, although post-GT consumption % CVC MAX 
readings were elevated for both groups (Table 5). 
 
Initial peak 
Raw CVC 
There was a statistically-significant difference between groups at the beginning of the intervention 
for Raw CVC at initial peak with the older group demonstrating a lower value. There was not a 
significant difference at the end of the intervention between groups; however, there were 
statistically-significant improvements within both groups (Table 5). 
 
  
 
 
 
 
 
 
 
 
 
*p<0.05 between visits (within groups) 
† p<0.05 between groups (at the same time-point) 
Table 5: Cutaneous Vascular Conductance of the Experimental Groups 
% CVC MAX 
There were no statistical significant differences between CVC MAX at both visits, although post-
GT consumption % CVC MAX values were increased for both groups (Table 5). 
 
Plateau 
Raw CVC 
There was a statistically-significant difference between groups pre-green, tea at the plateau stage for 
Raw CVC, with the older group having a lower reading than the younger group (e.g. 1.45 (0.45) vs 
1.87 (0.79) respectively; p<0.05). Despite the increase in both groups, statistical significance 
remained at the end of the intervention (1.67 (0.47) vs 2.19 (0.87) for the older and younger group 
respectively; p<0.05). 
 
% CVC MAX 
 Group A 
(younger 
group) 
 Group B 
(older group) 
 
 Raw CVC %CVCMAX Raw CVC %CVCMAX 
Baseline 
Visit 1 (Pre-
intervention) 
0.25 (0.14) 10.7 (5.9) 0.31 (0.13) 10.8 (7.9) 
Visit 2 (Post-
intervention) 
0.5(0.41) 12.6(7.6) 0.39(0.15) 13.6(4.3) 
Initial Peak 
Visit 1 (Pre-
intervention) 
1.6 (0.59) 76.4 (23.1) 1.25 (0.58)† 65.6 (16.5) 
Visit 2 (Post-
intervention) 
2.05(0.72)* 87.1(17.6) 1.65 (0.5)* 77.8 (17.6) 
Plateau 
Visit 1 (Pre-
intervention) 
1.87 (0.79) 88.1 (19.9)† 1.45 (0.45)† 72.6 (22.5) 
Visit 2 (Post-
intervention) 
2.19 (0.87) 95.2 (19.5) 1.67 (0.47)† 86.2 (13.1)* 
Similarly to Raw CVC, pre-GT consumption %CVC MAX was significantly different between 
groups, with the older group having lower values (72.6 (22.5) vs 88.1 (19.9) respectively, p<0.05). 
The differences were diminished at the end of the intervention (95.2 (19.5) vs 86.2 (13.1), younger 
group vs older group respectively, p>0.05), with the older group achieving a statistically-significant 
improvement (72.6 (22.5) pre- vs 86.2(13.1) post-intervention, p<0.05) as well. 
 
Oxygen Tension 
All participants were categorised according to their sub-maximal exercise TcPO2 profile as 
previously described.  At baseline, we recorded a total of 12 healthy profiles and 3 disease profiles 
in each of the two groups. The intervention had no effect on their categorisation (Table 6).  
Baseline ΔTcPO2 did not differ significantly between groups and this continued in a similar trend 
after the intervention; but a statistical-significant difference was observed within groups at the end 
of the intervention, for both the younger and older groups (i.e. 7 (5.5) vs 9.7 (5.4), p<0.05 for the 
older group). A similar trend was also observed with ΔTcPO2max, with statistical significance being 
reached for both groups at the end of the intervention (Table 6, Figure 1). 
 
 
Heart Rate, Exercise Perceived pain (CR-10) and Exertion (RPE) Parameters 
 
 There was no significant variation at peak heart rate (beats/min) for participants during the sub-
maximal test, between visits, in both groups (e.g. 128 (17) vs 132 (25) for the older and younger 
group respectively, p>0.05). Similarly, no significant differences were observed between groups, 
pre- and post- intervention visits (Table 6). The average perception of pain and exertion were lower 
in the younger group when compared to the older group both prior and after GT consumption, with 
statistical significance being reached at both occasions (Table 6). At the end of the intervention 
statistical significance was observed for the exertion parameter in the younger group, but not for the 
pain element (Table 6). At the same time, statistical significance was observed in pain perception 
but not in felt exertion in the older group (Table 6). 
  Group A 
(younger 
group) 
p value 
(between 
visits) 
Group B 
(older 
group) 
p value 
(between 
visits) 
p value 
(between 
groups) 
ΔTcPO2 (mmHg) 
Visit 1 (Pre-
intervention) 
6.8 (7)  
0.04* 
7 (5.5)  
0.04* 
0.86 
Visit 2 (Post-
intervention) 
11.5 (6.5) 9.7 (5.4) 0.62 
ΔTcPO2max (mmHg) 
Visit 1 (Pre-
intervention) 
14.3 (9.7)  
0.04* 
12.1 (6)  
0.02* 
0.50 
Visit 2 (Post-
intervention) 
19.5 (8.2) 16.7 (6) 0.27 
In-Exercise Peak HR (beats/min) 
Visit 1 (Pre-
intervention) 
132 (25)  
0.9 
128 (17)  
0.08 
0.50 
Visit 2 (Post-
intervention) 
133 (23) 124 (19) 0.29 
CR-10 (pain) 
Visit 1 (Pre-
intervention) 
2 (1.5)  
0.3 
5 (3)  
0.01* 
0.002 
Visit 2 (Post-
intervention) 
1.5 (1.5) 4 (2) 0.01 
RPE (exertion) 
Visit 1 (Pre-
intervention) 
10 (3)  
0.04* 
15 (3)  
0.08 
<0.001 
Visit 2 (Post-
intervention) 
9 (2) 14 (2) <0.001 
TcPO2 Profile Categorization 
Visit 1 (Pre-
intervention) 
12 healthy, 3 
disease 
 
1.0 
12 healthy, 3 
disease 
 
1.0 
1.0 
Visit 2 (Post-
intervention) 
12 healthy, 3 
disease 
12 healthy, 3 
disease 
1.0 
*p<0.05 between visits 
Table 6: Comparison of Physiological and Exercise Data (obtained during Sub-maximal 
exercise testing) between Groups and Visits. 
 
Discussion 
Blood pressure 
 In our study, we noted a significant decrease in systolic blood pressure in both the younger and 
older group following 2 weeks of GT consumption. The inverse association between GT 
consumption and systolic and diastolic blood pressure is well-established: for example, a 2013 
Cochrane review on tea and blood pressure reported that in all 6 studies involving GT, a 
statistically-significant blood pressure reduction was observed (Hartley et al. 2013). Whilst 
significance was not reached in diastolic blood pressure post-consumption in our study, 
improvements were nonetheless evident in both groups. Our findings are therefore consistent with 
previous literature, in suggesting GT may have a beneficial effect on hypertension which in turn 
could reduce an individual’s risk of CVD (Sowers et al., 2001).  
 
Cutaneous Microvascular Function 
 Whilst there is at present, a lack of research on the effects of GT on microcirculation, a number of 
studies exploring vascular function in general have been published in the past. Fuchs and colleagues 
(2014), for example, examined the effect of catechins contained within GT on vascular functioning 
in 24 healthy men and women aged 45-75. The study found that 500 mg of GT catechins did result 
in a small but significant increase in readings, suggesting GT may have had a positive effect on 
vascular functioning. Similar results were observed by Jochmann and colleagues (2008) on the 
effect of catechins on endothelial functioning using Flow Mediated Dilatation (FMD). During our 
study, we attempted to expand those findings and explore the effects of GT consumption with 
regard to specific elements of vascular function, focusing on cutaneous microcirculation.  
 
We noted improvements in the initial peak stage in the older participants in our study following the 
GT intervention. The initial peak stage is a neurogenic phase, which is initiated by the activity of 
sensory nerves and is mediated by an axon-reflex (Minson et al. 2001).  A decrease in an 
individual’s nerve axon-mediated vasodilation has been associated with abnormalities in the 
microcirculation (Nouri et al. 2012). Such abnormalities may then lead to an increased risk of 
neuropathic changes and subsequently CVD (Kannel & McGee, 1979). It is important to note that 
as an individual ages there is a definable loss of organisation in the vessels of the microcirculation 
(Montagena and colleagues 1975). This subsequently impacts the skins ability to respond to local 
heating. Our finding is in-line with previous work on lifestyle interventions (exercise; Tew et al. 
2010, high-sodium diet; Greaney et al. 2012), which have been shown to reverse the ageing-
invoked reduction of axon-mediated vasodilation.  
 
In our study, we observed improvements in the plateau stage for the older [for example % CVC 
MAX 72.6 (22.5) increasing to 86.2 (13.1)] and younger group [% CVC MAX 88.1 (19.9) 
increasing to 95.2 (19.5)]. As the plateau stage is largely mediated by NO, this suggests the NO 
levels in our participants has increased, without however, this increase reaching levels of statistical 
significance.  As reduced bio-availabilty of NO is thought to lead to a loss of cardio-protective 
actions and may even increase the progression of CVD (Naseem 2005), maintaining NO at 
acceptable levels can reduce CVD risk. This is consistent with previous literature in which an 
increase in NO vasodilation was observed following the administration of specific phenols 
contained within GT (epicatechin and epigallocatechin) (Huang et al. 1999; Lorenz et al. 2004). 
The observed trend makes further research – based on an intervention that would be of greater 
duration and potentially include a more complex diet – the next logical step in this area. 
 
Skin Oxygen Tension 
 In an attempt to explore the effects of GT on microvascular function during every day mild 
physical activity (such as walking, lifting and climbing stairs), we assessed TcPO2 changes during 
sub-maximal exercise.    
It is well accepted that older people are susceptible to reduced oxygen perfusion due to degradation 
of endothelium dependent NO by free radicals. Their source varies and can be obtained both from 
the diet and environmental assaults accumulating over time (Gerhard et al. 1996). Such assaults 
may eventually cause the arteries to narrow enough to reduce blood flow/cause total occlusion 
resulting in high BP/ cardiac arrest (Stary et al. 1995).  Our study is the first to report a significant 
improvement in oxygen tension under provocation (e.g. exercise testing) at the end of a GT 
intervention in both younger and older groups. This may provide an indication that such subtle 
arterial defect could be reversed or supressed with GT supplementation in the short-term, in healthy 
but sedentary populations. This expands on earlier findings by Fuchs et al. (2014) who reported 
significant improvements in hyperaemia following a 12-day intervention.  
 
We observed significant improvements in both the younger and older group in ΔTcPO2max (oxygen 
tension) when comparing groups between visits. However a greater improvement was observed in 
the older group, suggesting that older people may derive more benefits from a GT-based 
intervention. On the other hand, GT consumption appeared to have no effect on the TcPO2 profiles 
of the participants in our study, with no changes observed between visits.  More importantly no 
improvement was detected in participants classified as having a “disease” profile, as described by 
Ouedraogo and colleagues (2011). However, it must be noted that such profiles have been reported 
not only in people with cardiovascular impairments but also in healthy individuals (Kubota & 
Zoladz, 2005). Therefore assumptions made about the wellbeing of individuals classified as 
“diseased” in reference to TcPO2 categorisation, should be treated with caution.  
 
Nevertheless, it appears that although GT can improve skin oxygen tension under provocation, this 
improvement is related to quantity and not quality, as the latter remains unaffected. Evidently 
however, further research would be needed to substantiate our findings and explore the 
mechanisms, which are motivated by GT consumption and affect skin oxygen tension when oxygen 
demand is higher.   
 
Experimental concerns  
All participants in our study were healthy, with no overt chronic disease effecting their 
microvascular functioning. It is therefore difficult to ascertain whether similar results would have 
been achieved had the population had an alternative health status, and indeed how well our results 
could therefore be extrapolated to the wider population. Future studies need to explore this.  
Conclusions 
Our results are consistent with the existing literature base purporting GT’s positive effect on 
cardiovascular risk markers (Peng et al. 2014; Velayutham et al. 2008).  It supports the notion that 
GT may protect against cardiovascular disease and that there may be merit therefore in introducing 
it into the diet of those most at risk of developing the disease. Exercise and various other dietary 
elements of an individual’s lifestyle however have been linked to reducing the risk of CVD and 
therefore must also be taken into consideration (Kromhout et al., 2002). There is a need therefore 
for further research to substantiate the significance of our observations. 
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Figure Legend 
Figure 1: ΔTCPo2max comparison between groups, prior and after 14 days of green tea 
consumption (*p<0.05). 
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